Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Talapo Therapeutics Inc
Profile last edited on: 7/19/2023      CAGE: 7P4N6      UEI: ----------

Business Identifier: Obesity treatments
Year Founded
2015
First Award
2018
Latest Award
2018
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2223 Avenida De La Playa Suite 206
La Jolla, CA 92037
   (858) 248-9253
   N/A
   www.talapobio.com
Location: Single
Congr. District: 50
County: San Diego

Public Profile

Structured around the development of cellular therapeutics designed to treat obesity, Talapo Therapeutics is employing cellular therapeutics agents to target growth factors with roles in adipogenesis. The effort is to block the cellular process of producing fat tissue thus inhibiting the storage of fat and enabling patients to get effective anti-obesity treatments.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$515,114
Phase II Dollars
$0
Total Awarded
$515,114

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2018 1 NIH $290,134
Project Title: Targeting TGF-Beta Growth Factors to Treat Obesity
2018 1 NIH $224,980
Project Title: Cerberus Therapy for Metastatic Disease

Key People / Management

  Davorka Messmer -- Chief Executive Officer

  Erik Martinez-Hackert -- Founder & CSO

  Neil Senturia -- Executive Officer & Chairman

Company News

There are no news available.